Weight-Loss Drugs Could Save US Airlines $580 Million Per Year

An anonymous reader quotes a report from the New York Times: Weight-loss drugs like Ozempic have transformed millions of lives with easily administered treatments and quick results. Now it turns out the dropped pounds may have a surprising perk for airlines, too: lower fuel costs, as slimmer passengers lighten their aircraft’s loads. According to a […]

GLP-1 weight-loss drugs show early promise for treating addiction

This systematic review evaluates preclinical and clinical evidence on glucagon-like peptide-1 receptor agonists as potential treatments for substance use disorders. Findings show consistent reductions in drug- and alcohol-seeking behaviors in animal models, while human evidence remains limited, heterogeneous, and preliminary.

Worrisome retail trends flagged at Dollar Tree

Like millions of Americans, I like a good deal. With sticky inflation and rising layoffs, finding bargains has become a new American pastime, which should be great news for discount retail chains like Dollar Tree. After all, it’s arguably tough to find a better price than at Dollar Tree, which sells many items for $1.25. […]

Ozempic is Reshaping the Fast Food Industry

New research from Cornell University has tracked how households change their spending after someone starts taking GLP-1 medications like Ozempic and Wegovy, and the numbers are material enough to explain why food industry earnings calls keep blaming everything except the obvious culprit. The study analyzed transaction data from 150,000 households linked to survey responses on […]

Why Patient Understanding is the Most Important Metric You Aren’t Tracking

Aayush Sisodia, MSHI, BDS, Business Analytics Advisor, Pharmacy Analytics Health systems are drowning in metrics. We can tell you how many portal messages were answered within 24 hours, how many patients closed a care gap, and how many clinicians are using ambient AI in their notes. But there is one question our dashboards rarely answer: […]

What doctors won’t tell you about Ozempic side-effects

Whether you like them or not, weight-loss drugs have changed the world. Obesity levels in the US, which had been on the rise for years, are falling. National spend on food has shrunk, fashion outlets are selling fewer XXL-sized clothes and, here in the UK, one supermarket has even launched a ‘nutrient dense’ food range, […]

Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide. Epidemiological evidence indicates that MASLD is associated with an increased risk of developing colorectal cancer (CRC). MASLD and CRC share many common risk factors and pathophysiological mechanisms, but an optimal strategy for identifying and managing CRC risk in individuals with […]